Interdisciplinary Approach by Hyperthermia and Cancer Gene Therapy.
スポンサーリンク
概要
- 論文の詳細を見る
Hyperthermic therapy has been applied in many advanced malignancies, but tumor regression occurs only in thermo-sensitive cancers. To elucidate ways to overcome thermo-resistance and to improve the therapeutic efficiency of treating thermo-resistant cancers, we devised a novel application of cancer gene therapy in conjunction with hyperthermia. This strategy allows for selective cancer gene therapy under control of the heat-inducible HSP promoter. Heat-inducible activity of HSP promoter was examined in FM3A breast cancer cell line and MKN45 gastric cancer cell line using a luciferase assay reporter gene system. HSP promoter activity increased markedly following heat shock, and this increase depended on temperature and duration of treatment. Based on these results, we designed a suicide gene therapy using the <I>Herpes simplex</I> virus thymidine kinase gene ligated to the heat-inducible HSP promoter (HSP-tk). In <I>in vitro</I> cytotoxic assays HSP-tk transduced cells following heat treatment became 50, 000 times more sensitive than either non-transduced cells or HSP-tk transduced cells without heat treatment to ganciclovir (GCV). Immunohistochemical analysis revealed that Fas-mediated apoptosis was involved in the synergistic killing effect of combination therapy. Next, we examined the efficacy of HSP-tk gene therapy <I>in vitro</I>, cancer cell lines implants in subcutaneous or intraperitoneal models of balb/c nude mice were targeted using the HVJ-anionic-liposome method. Significant inhibition of tumor growth was observed in HSP-tk transduced tumors following hyperthermia as more than half of treated-mice showed complete tumor eradication. Prolonged survival was also observed in HSP-tk transducted mice with hyperthermia. In contrast, non-transduced mice treated with or without hyperthermia showed no prolongation of survival. Recently, another group reported an <I>in vitro</I> study that HSP promoter-mediated gene therapy is an effective treatment for prostate cancer studied. Taken together, these results demonstrate that the combined gene and hyperthermic therapy may be a feasible treatment that can target HSP-expressing carcinomas, even in advanced cases.
- 日本ハイパーサーミア学会の論文
日本ハイパーサーミア学会 | 論文
- わが国における温熱療法のあゆみと現状:2004年のアンケート調査
- 癌治療における併用療法としての低温度温熱処置の有用性について
- The Biology of Heat-induced DNA Double-Strand Breaks
- 良好な生存率を示した非小細胞肺癌の化学療法とハイパーサーミアの併用療法
- 温熱感受性ならびに温熱効果の修飾について